Ethical use of placebos and provocative testing in diagnosing nonepileptic seizures
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
One important reason for therapeutic failure of epilepsy treatment is misdiagnosis of epilepsy. Several imitators of epilepsy [1] can confound even experienced clinicians. Among these imitators, nonepileptic (psychogenic) seizures (NES) can be particularly difficult to diagnose. Induction of NES by hypnosis or suggestion has been used since 1955. [2] This diagnostic maneuver, although useful, raises ethical issues pertaining to employment of placebos, informed consent, and the effect of deception on the patient-doctor relationship. In this review, we examine provocative testing for seizures in light of these issues.
Placebo use in medicine.
Neurologists use placebos during provocative testing to diagnose suspected conversion symptoms. Recent reviews address ethical issues of placebo use in controlled studies. [3] Here, we review a brief history of the placebo and consider ethical issues related to placebo use in provocative testing.
The therapeutic benefits of placebos have been recognized, directly or indirectly, since the dawn of civilization. Given the severe limitations of pharmacologic and surgical therapies until the current century, administration of a placebo was among the most effective therapeutic strategies. Robert Burton (1628) [4] recognized that "a silly chirurgeon, doth more strange cures than a rational physician ... because the patient puts his confidence in him." Mesmer's use of animal magnetism during the late 18th century, although disproved as fraudulent, became the forerunner of hypnotism and helped shape the future of dynamic psychiatry. [5] Thomas Jefferson (1807) viewed placebos as a "pious fraud," but noted that "One of the most successful physicians ... used more of bread pills, drops of colored water, and powders of hickory ashes, than of all other medicines put together." [6] In the late 19th century, Charcot used hypnosis and suggestion to explore various neuropsychiatric disorders, including conversion. In pioneering studies, he hypnotized patients to produce and relieve hysterical paralysis, mutism, and amnesia. Unfortunately, some of …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Views And Reviews
Psychogenic SeizuresRonald P. Lesser et al.Neurology, June 01, 1996 -
Review
Psychogenic nonepileptic seizures and movement disordersA comparative reviewRoberto Erro, Francesco Brigo, Eugen Trinka et al.Neurology: Clinical Practice, March 08, 2016 -
Articles
Epileptic seizures progressing into nonepileptic conversion seizuresOrrin Devinsky, Elisabeth Gordon et al.Neurology, November 01, 1998 -
Articles
Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizuresW.C. LaFrance, Jr., G.I. Keitner, G.D. Papandonatos et al.Neurology, August 25, 2010